Eli Lilly and Company (LLY) has announced that the European Commission has approved the use of Zypadhera (olanzapine powder and solvent for prolonged release suspension for injection, also known as ...
Zypadhera(TM) Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP) for Maintenance Treatment of Schizophrenia INDIANAPOLIS, Sep. 26, 2008 (Canada NewsWire ...
December 15, 2009 — The US Food and Drug Administration (FDA) has approved olanzapine extended-release intramuscular injection (Zyprexa Relprevv, Eli Lilly & Company) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results